Samar Ojaimi, Tony M. Korman

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review


Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazole- [5,4c]-rifamycin SV) is a synthetic antimicrobial and derivative of rifamycin (Jiang and DuPont, 2005; Scarpignato and Pelosini, 2005; Finegold et al., 2009). It was first described as compound L-105 in 1982 and marketed in Italy in 1987 (Huang and DuPont, 2005; Scarpignato and Pelosini, 2005). Its empirical formula is C43H51N3O11 and its molecular weight is 785.9 Da; the chemical structure is shown in Figure 128.1.

Original languageEnglish
Title of host publicationKucers the Use of Antibiotics
Subtitle of host publicationA Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs
EditorsM. Lindsay Grayson
Place of PublicationBoca Raton FL USA
PublisherCRC Press
Number of pages13
ISBN (Electronic)9781498747967
ISBN (Print)9781498747950
Publication statusPublished - 2 Oct 2017

Cite this